Subjective and objective comparison of critical care pathways for open donor nephrectomy
| Autor: | Melinda K, Knight, David S, DiMarco, Robert P, Myers, Matthew T, Gettman, Mercedeh, Baghai, Donald, Engen, Joseph W, Segura |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Pain
Postoperative Morphine Anti-Inflammatory Agents Non-Steroidal Analgesia Patient-Controlled Length of Stay Injections Intramuscular Kidney Transplantation Nephrectomy Analgesia Epidural Analgesics Opioid Postoperative Complications Costs and Cost Analysis Critical Pathways Living Donors Tissue and Organ Harvesting Humans Laparoscopy Ketorolac Retrospective Studies |
| Zdroj: | The Journal of urology. 167(6) |
| ISSN: | 0022-5347 |
| Popis: | In the era of minimally invasive techniques and cost containment, care pathways after donor nephrectomy are important. While open donor nephrectomy remains the established procedure, questions regarding the surgical approach, postoperative care and patient morbidity/dissatisfaction have surfaced. We compared results of standard and fast-track care pathways after donor nephrectomy.Between January 1998 and August 1999, 60 patients underwent open donor nephrectomy. By surgeon preference, patients received either ketorolac only (31), ketorolac plus morphine spinal (17) or patient controlled anesthesia (12). Data related to surgery, hospital course and cost were reviewed. Patients were surveyed regarding return to daily activities and groups were statistically analyzed.The mean dose per patient was 183 (ketorolac only), 180 (ketorolac plus morphine spinal) and 69 (patient controlled analgesia) mg. Median hospital stay was 2 days for the fast-track pathways (ketorolac only, ketorolac plus morphine spinal) compared to 3 days for the patient controlled analgesia group (p0.001). Delayed oral intake was seen in 6% of patients on ketorolac only and 3% for those on ketorolac plus morphine spinal compared to 83% of the patient controlled analgesia group (p0.001). Return to exercise (median weeks, p0.79) was 2 for the ketorolac only group, 3.5 for ketorolac plus morphine spinal and 3.5 for patient controlled analgesia. Mean global cost was $9,394 for the ketorolac only group, $9,238 for ketorolac plus morphine spinal and $11,601 for patient controlled analgesia (p0.02).Fast-track pathways significantly shortened hospital stay and quickened oral intake. Cost was significantly contained using new pathways. Resumption of daily activities was comparable among the groups. Comparisons of critical care pathways are required to optimize patient care after kidney donation. Prospective trials are needed to verify our results. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|